Lifestyle Changes in PCOS with OSA and NAFLD
Launched by CAIRO UNIVERSITY · Sep 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how lifestyle changes can help women who have Polycystic Ovary Syndrome (PCOS), as well as issues like obstructive sleep apnea (OSA) and fatty liver disease (NAFLD). These conditions are often seen together in women with PCOS, and the trial aims to see if making healthier lifestyle choices can improve their overall health.
To participate in this study, women aged between 18 and 40 who are experiencing symptoms of PCOS, have been diagnosed with obstructive sleep apnea, are considered obese, and have fatty liver disease can sign up. However, women with certain serious health conditions, like heart or kidney problems, cancer, or who are pregnant, will not be eligible. If you join the trial, you can expect to learn more about healthy lifestyle changes and how they might help your symptoms. The trial is currently looking for participants, so if you or someone you know fits these criteria, it might be a good opportunity to consider.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • forty women
- • women complaint PCOS
- • women complain obstructive sleep apnea
- • women are obese
- • women complain fatty liver
- Exclusion Criteria:
- • cardiac insult
- • renal insult
- • malignacy
- • pregnancy
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dokki, Giza, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported